You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The companies say that the integration of the Nvidia DGX Station A100 will support "real-time analyses" of long-read DNA and RNA sequences.
The collaboration builds on an oligonucleotide supply agreement the partners signed in 2019 for Clear Labs' nanopore sequencing-based food safety testing.
In PNAS this week: effect of mutagenic compounds on transcription in yeast, role for GATA6 in regulating sinus node development, and more.
Australian researchers say a nanopore sequencing strategy could quickly trace the source of a SARS-CoV-2 infection, according to Reuters.
During its Nanopore Community Meeting, held online this year, the firm announced several product releases, technology improvements, and development projects.
In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.
Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.
Angstrom Bio is developing a rapid, scalable coronavirus test that uses nanopore sequencing to detect barcoded PCR products.
The approach, which is developed for both Illumina and nanopore sequencing, had high sensitivity and specificity for identifying bacteria and fungi.
In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.
Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.
According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.
In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.